Skip to content

Insider · CIK 0001825009

Frederic Guerard

director

Files at CALC (CalciMedica, Inc.), LENZ (LENZ Therapeutics, Inc.). First filing -, latest -.

Frederic Guerard files SEC Form 4 as director at CALC (CalciMedica, Inc.), and also at LENZ (LENZ Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Frederic Guerard has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 7 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Oct 1, 2026CALC
CalciMedica, Inc.
AGrant or award
Director Stock Option (Right to Buy)derivative
+20,000$0.00$020,0008 d ago
Jun 15, 2026LENZ
LENZ Therapeutics, Inc.
AGrant or award
Stock Option (right to buy)derivative
+22,100$0.00$022,100Jun 15, 2026
Jun 24, 2025CALC
CalciMedica, Inc.
AGrant or award
Director Stock Option (Right to Buy)derivative
+10,000$0.00$010,000Jun 26, 2025
Jun 24, 2025CALC
CalciMedica, Inc.
AGrant or award
Director Stock Option (Right to Buy)derivative
+5,000$0.00$05,000Jun 26, 2025
Jun 24, 2025CALC
CalciMedica, Inc.
AGrant or award
Director Stock Option (Right to Buy)derivative
+15,000$0.00$015,000Jun 26, 2025
Jun 24, 2025CALC
CalciMedica, Inc.
AGrant or award
Director Stock Option (Right to Buy)derivative
+10,000$0.00$010,000Jun 26, 2025
Jun 11, 2025LENZ
LENZ Therapeutics, Inc.
AGrant or award
Stock Option (right to buy)derivative
+13,500$0.00$013,500Jun 11, 2025

Questions about Frederic Guerard

Answered from the filings on this page, as of the latest one.

Is Frederic Guerard buying or selling?

Frederic Guerard has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Frederic Guerard's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Frederic Guerard has 0.

Where does Frederic Guerard file Form 4?

Frederic Guerard has filed Form 4 at CALC (CalciMedica, Inc.); LENZ (LENZ Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Frederic Guerard: insider trades and track record | InsiderTell